Hot Topics: What we learned from SITC20 about an emerging class of oncology agents
As we get into the final swing of the Fall cancer conference season, at SITC this weekend there was much to think about in terms of early stage oncology drug development.
Still, it did feel rather surreal not to be in Maryland at the Gaylord National Centre in National Harbor for a live meeting this year, especially considering this particular specialist IO meeting tends to be held in a small jam-packed hall with nary an empty seat to be had!
I thought it would be fun to focus on an area which is slowly receiving more attention, with at least one sub category actually beginning to look quite promising indeed…
To learn more from our oncology analysis and get a heads up on the latest insights and commentary pertaining to the SITC annual meeting, subscribers can log-in or you can click to gain access to BSB Premium Content.
This content is restricted to subscribers